Glipizide 5 mg – Generic Diabetes Medication

Product Overview

Glipizide 5 mg is a generic oral antihyperglycemic agent indicated for the management of type 2 diabetes mellitus. Manufactured by USV Pvt Ltd, each strip contains ten sustained‑release tablets, each delivering 5 mg of glipizide. The product is packaged in strengths of 5 mg per tablet and is available in pack sizes of 60, 90, or 120 tablets, providing flexible options for patients and clinicians seeking consistent glycemic control.

What is Glipizide?

Glipizide belongs to the sulfonylurea class of medications and functions as an oral hypoglycemic agent that stimulates insulin release from pancreatic beta cells. It is chemically described as a white to off‑white crystalline powder with the molecular formula C_16H_17ClN_2O_4S. While the active ingredient is glipizide, the formulation includes excipients that ensure sustained release over approximately 24 hours, allowing once‑daily dosing. This medication is listed in authoritative drug databases such as Drugs.com and is referenced in the NIH’s PubChem database for its pharmacological profile.

Uses and Benefits

The primary use of glipizide 5 mg is to lower blood glucose levels in adults with type 2 diabetes when diet and exercise alone are insufficient. Clinical studies have demonstrated that glipizide effectively reduces fasting plasma glucose and post‑prandial glucose excursions, leading to improved glycemic control as measured by HbA1c reductions of approximately 0.5 to 1.0 percent when used as monotherapy or in combination with metformin or insulin. Benefits include convenient once‑daily administration, a well‑characterized safety profile, and cost‑effectiveness compared with many branded alternatives.

How It Works

Glipizide acts by binding to the sulfonylurea receptor (SUR1) on the surface of pancreatic beta cells, causing a conformational change that opens ATP‑sensitive potassium channels. This leads to depolarization of the beta‑cell membrane, influx of calcium, and ultimately stimulates insulin secretion in a glucose‑dependent manner. The sustained‑release formulation ensures a steady plasma concentration, minimizing peaks and troughs and providing prolonged glycemic control throughout the day.

Dosage Guidelines

Typical dosing begins with one 5 mg tablet taken orally once daily, preferably before the first main meal of the day. The dose may be titrated upward in increments of 5 mg based on glycemic response, with a maximum recommended daily dose of 20 mg (four tablets). Adjustments are recommended for patients with renal impairment or hepatic dysfunction, and special caution is advised in elderly patients who may be more susceptible to hypoglycemia. It is essential to monitor blood glucose regularly and to educate patients on recognizing the signs of low blood sugar.

Side Effects

Like all medications, glipizide can cause adverse effects. The most commonly reported side effects include hypoglycemia, dizziness, headache, nausea, and mild skin rash. Rare but serious adverse reactions may involve hepatic enzyme elevations, severe skin reactions, or hypersensitivity. Patients should discontinue use and seek medical attention if they experience symptoms of severe hypoglycemia (e.g., confusion, seizures) or signs of an allergic reaction such as swelling of the face, lips, or throat.

Warnings and Precautions

Glipizide is contraindicated in patients with type 1 diabetes or diabetic ketoacidosis. Caution is advised in individuals with a history of cardiovascular disease, hepatic or renal impairment, or those who are pregnant or breastfeeding. Concomitant use with certain medications such as certain antibiotics, antifungals, or beta‑blockers may increase the risk of hypoglycemia. Patients should avoid alcohol consumption while on therapy, as it can potentiate the hypoglycemic effect. Always consult a healthcare professional before initiating or modifying treatment.

Frequently Asked Questions

Can glipizide be taken with meals?

Yes, glipizide is usually taken before the first main meal of the day to align its glucose‑lowering effect with nutrient absorption, but it can also be taken with breakfast if that better fits the patient’s routine.

Is glipizide safe for patients with kidney disease?

Glipizide can be used in mild to moderate renal impairment, but dose reduction is recommended for patients with severe renal dysfunction (eGFR < 30 mL/min). A healthcare provider should evaluate kidney function before prescribing.

How does glipizide differ from other sulfonylureas?

Glipizide has a shorter half‑life and a lower risk of causing prolonged hypoglycemia compared with some older sulfonylureas, and its sustained‑release formulation allows once‑daily dosing with more stable plasma levels.

What should I do if I miss a dose?

If a dose is missed, it should be taken as soon as remembered unless it is near the time of the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed; double dosing should be avoided.

Are there any dietary restrictions while on glipizide?

No specific foods are prohibited, but patients should maintain a consistent carbohydrate intake and follow a balanced diet and exercise plan to achieve optimal glycemic control. Alcohol should be consumed cautiously due to its hypoglycemic potential.

For additional detailed prescribing information, refer to the FDA’s drug label guidance or consult a qualified healthcare professional.

Related Products

• Erytop Gel (Clindamycin)
• Okamet 500 Mg (Metformin)
• Angispan TR (Nitroglycerin/Glyceryl Trinitrate)
• Angispan TR 2.5 mg (Nitroglycerin/Glyceryl Trinitrate)
• Angispan TR 6.5 mg (Nitroglycerin/Glyceryl Trinitrate)
• Glimepiride 2 mg (Generic)
• Glimepiride 1 mg (Generic)
• Glycomet-GP 0.5 Forte (Metformin/Glimepiride)
• Glycomet-GP 0.5 Tablet (Metformin/Glimepiride)
• Forxiga 5mg (Dapagliflozin)
• Glycomet-GP 1 Tablet (Metformin/Glimepiride)
• Amaryl M 1mg (Metformin/Glimepiride)